These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193 [TBL] [Abstract][Full Text] [Related]
10. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates. Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772 [TBL] [Abstract][Full Text] [Related]
11. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. Altar CA; Kim H; Marshall JF J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277 [TBL] [Abstract][Full Text] [Related]
12. D2-like dopamine receptor density in Tourette syndrome measured by PET. Wong DF; Singer HS; Brandt J; Shaya E; Chen C; Brown J; Kimball AW; Gjedde A; Dannals RF; Ravert HT; Wilson PD; Wagner HN J Nucl Med; 1997 Aug; 38(8):1243-7. PubMed ID: 9255158 [TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone. Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165 [TBL] [Abstract][Full Text] [Related]
14. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography. Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148 [TBL] [Abstract][Full Text] [Related]
15. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study. Przedborski S; Kostic V; Jackson-Lewis V; Cadet JL; Burke RE J Neurochem; 1991 Dec; 57(6):1951-61. PubMed ID: 1834800 [TBL] [Abstract][Full Text] [Related]
16. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors. Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364 [TBL] [Abstract][Full Text] [Related]
17. Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography. Hartvig P; Eckernäs SA; Ekblom B; Lindström L; Lundqvist H; Axelsson S; Fasth KJ; Gullberg P; Långström B Acta Neurol Scand; 1988 Apr; 77(4):314-21. PubMed ID: 3260438 [TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative movement disorders: the contribution of functional imaging. Piccini P Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543 [TBL] [Abstract][Full Text] [Related]
19. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917 [TBL] [Abstract][Full Text] [Related]
20. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. Leenders KL; Frackowiak RS; Quinn N; Marsden CD Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]